NCI’s Douglas R. Lowy and John T. Schiller Awarded Sabin Medal
The NCI scientists whose discovery provided the technology for commercially developed human papillomavirus (HPV) vaccines received the Albert B. Sabin Gold Medal Award from the Sabin Vaccine Institute.
Drs. Douglas R. Lowy and John T. Schiller of the Laboratory of Cellular Oncology in NCI’s Center for Cancer Research are the first and second inventors on government-owned patents for HPV vaccines licensed to Merck & Co., Inc., and GlaxoSmithKline. As a direct result of their work, vaccines now exist that prevent infections with high-risk, or cancer-causing, HPV types and with HPV types that cause genital warts.
The Sabin Medal is given annually to acknowledge extraordinary contributions made by scientists in the field of vaccine research. The award commemorates Dr. Albert B. Sabin, who developed the oral polio vaccine.
The third of four telephone workshops in NCI’s annual “Living With, Through, and Beyond Cancer” series will be held June 14 from 1:30 to 2:30 p.m. EDT. Part III of the series is titled “Stress Management for Caregivers: Taking Care of Yourself Physically and Emotionally.”
The free series offers cancer survivors, family members, friends, and health care professionals practical information to help them cope with concerns and issues that arise after treatment ends. The workshops are presented by CancerCare, in collaboration with NCI, LIVESTRONG, the American Cancer Society, the Intercultural Cancer Council, Living Beyond Breast Cancer, and the National Coalition for Cancer Survivorship.
Speakers for the June 14 workshop include Dr. Guadalupe Palos, a clinical research manager at the University of Texas M. D. Anderson Cancer Center; Dr. David Kissane, chair and attending psychiatrist at Memorial Sloan-Kettering Cancer Center; and Dr. Laurel Northouse, professor of nursing at the University of Michigan and co-director of the sociobehavior program at the University of Michigan Comprehensive Cancer Center.
Part IV, “Fear of Recurrence and Late Effects: Living With Uncertainty,” will take place on July 12.
These workshops are free; no phone charges apply. To register, visit CancerCare. If you missed part I or II of the series, podcasts are available here and here.
NCI is accepting applications for a new pilot mentorship program as part of the Research to Reality (R2R) online community of practice. The purpose of the program is to help cancer control practitioners develop the knowledge, understanding, and skills needed to identify, adapt, implement, and evaluate evidence-based cancer control and prevention interventions in community or clinical settings.
The 12-month mentorship program is designed as a distance-learning opportunity that will link mentees with experienced public health professionals through in-person meetings and training sessions, video conferencing, e-mail, and webinars. With guidance from their mentors and ongoing technical assistance and training from NCI, mentees will work on year-long cancer control and prevention projects relevant to their current jobs.
The mentor–mentee teams will also share their work and lessons learned with the R2R online community through discussion forums, cyber-seminars, and other interactive features as a way to extend the program’s reach.
The application process is competitive, and a maximum of six mentees will be selected to participate. More information and applications are available on the mentorship page of the R2R Web site. The application deadline is June 30.
NCI’s Office of Cancer Complementary and Alternative Medicine (OCCAM) released the spring 2011 issue of NCI CAM News, a twice-yearly newsletter with information on NCI’s latest complementary and alternative medicine (CAM) activities. The newsletter highlights NCI-sponsored CAM research, resources for researchers such as funding opportunities and grant writing workshops, and upcoming meetings and lectures.
Articles in this issue include:
- New and Improved: The NCI’s Best Case Series Program Now Designated as a Protocol
- What’s the Deal When We Heal? Exploring the Science of Healing
- Cancer Survivors are More Likely to Use CAM Compared with Non-Cancer Survivors
- Walk this Way: Clinical Center Labyrinth Provides Opportunity for Meditation and Reflection
Past newsletters are available online.